Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

NCT00758199 is registered in ClinicalTrials.gov with Bp Consulting, Inc as lead sponsor.

NCT NCT00758199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00758199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
Lead sponsor
Bp Consulting, Inc
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2008
Completion date
January 31, 2010
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataracts